Selective ghrelin/GHS receptor agonist (GHRP class) studied in GH-pulse research.
Also known as
IPA · GHRP · Ghrelin mimetic · Growth hormone secretagogue
Overview
Ipamorelin is a selective growth-hormone secretagogue (GHRP-class ghrelin-receptor agonist) studied for relatively clean GH-pulse induction with limited ACTH/cortisol co-secretion in classic comparative literature.
It is a staple GH-axis research tool, often combined with GHRH analogs. Left Turn Adventures supplies this compound for laboratory and research use only.
Proven benefits
Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.
GHS-R1a / ghrelin-receptor GH-pulse endpoints
- Selective secretagogue markers versus GHRP-2/6
- IGF-1 axis co-readouts where studied
- Appetite and gastric co-markers in ghrelin-pathway work
- Combination designs with GHRH analogs (research framing only)
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: GH-axis pulse and IGF-related markers beginning to register in short observation windows.
- Week 3–4: Clearer GH/IGF pathway readouts and recovery-adjacent markers in research models.
- Month 2–3: Body-composition and soft-tissue endpoints more apparent in extended preclinical designs.
- Month 3–6: Sustained GH-axis and composition-related observations where protocols run longer.
Footer RUO
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.